A simple strategy could make first-line antibiotics more effective against resistant bacteria
Researchers have identified a single, simple metric to inform medication regimen design that could bring an entire arsenal of first-line antibiotics back into the fight against drug-resistant pathogens.
A computer simulation created by Hannah Meredith, a biomedical engineering graduate fellow at Duke University, revealed that a regimen based on a pathogen’s recovery time could eliminate an otherwise resistant strain of bacteria. In theory, a database of recovery times for bacterial and antibiotic combinations could allow first-line antibiotics to clear many resistant infections.
Meredith has already begun lab work to create such a database, and early tests are confirming her model’s predictions.
The study appears in PLOS Computational Biology on April 23, 2015.
“Bacteria are forming resistance to antibiotics faster than we can make new ones, so there is a real need to use the antibiotics that are already on the market more efficiently,” said Meredith. “We hope this research will help hospitals improve patient outcomes while also making our antibiotics last as long as possible.”
The computer simulation models the relationship between bacteria, antibiotics and a method of resistance called beta-lactamase—an enzyme that degrades beta-lactam antibiotics, one of the largest and most-used classes of antibiotics. Many beta-lactam antibiotics are currently disregarded out of concern for the infection being completely resistant to that type of antibiotic—even if the antibiotic appeared to be effective in the lab. The new model, however, reveals that the infection might be temporarily sensitive to the antibiotic before the beta-lactamase degrades the drug and allows the infection to recover.
“You can think of this as a race between the cells and the antibiotics,” said Lingchong You, the Paul Ruffin Scarborough Associate Professor of Biomedical Engineering at Duke and Meredith’s advisor. “Before their beta-lactamase degrades the antibiotics, the cells are still sensitive and can be killed. But the antibiotics degrade faster than the cell population declines, allowing some cells to survive and repopulate.”
When clinicians realize an infection is resistant, they often skip straight to some of the strongest antibiotics available. But the study indicates that if they instead changed the dosing frequency of first-line antibiotics such that each dose is delivered while the bacteria are weakened during their recovery period, some infections could be cleared without skipping to the last resort.
Doctors also need to be careful, however, not to wreck native populations of bacteria vital to human health. A database detailing the responses of different strains to different antibiotics could allow Meredith’s computer model to determine the most efficient regimen to keep total exposure to a minimum. It could also indicate if multiple doses would not work, letting clinicians know when it is time to call in the heavy artillery.
Read more: Finding New Life for First-Line Antibiotics
The Latest on: Antibiotics
via Google News
The Latest on: Antibiotics
- Animal Antibiotics Antimicrobials Market Witness Growth Acceleration during 2021-2025|Says Kenneth Researchon March 5, 2021 at 10:05 am
The global Animal Antibiotics and Antimicrobials market was valued at USD 3.76billion in 2016 and is projected to reach USD 5.60 billionby 2025, growing at a CAGR of 4.54% from 2017 to 2025. Animal ...
- Veterinary Antibiotics Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027on March 5, 2021 at 6:35 am
The Global Veterinary Antibiotics Market is estimated to value over USD 1.7 billion by 2027 end at a CAGR of over 6.7% during the forecast period 2020 to 2027. The report for Veterinary Antibiotics ...
- Popeyes Announces Plans To Remove Artificial Ingredients, Antibioticson March 2, 2021 at 6:00 am
Popeyes announced new food quality and sustainability commitments as part of a 5-year plan facilitated by parent company Restaurant Brands International. Those commitments extend from its food to its ...
- Antibiotics Market Size Worth $57.99 Billion By 2028 | CAGR: 4.5%: Grand View Research, Inc.on March 1, 2021 at 6:05 pm
The global antibiotics market size is expected to reach USD 57.99 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 4.5% from 2021 to 2028.
- Searching for novel targets for new antibioticson February 28, 2021 at 4:00 pm
Ribosome formation is viewed as a promising potential target for new antibacterial agents. Researchers from Charité - Universitätsmedizin Berlin have gained new insights into this multifaceted process ...
- Bacteria use slimy strategy to defeat antibiotics that fight cystic fibrosison February 27, 2021 at 2:47 am
University of Montana researchers and their partners have discovered a slimy strategy used by bacteria to defeat antibiotics and other drugs used to combat infections afflicting people with cystic ...
- Doctors treat female UTIs with wrong antibiotics nearly half the time, study findson February 24, 2021 at 7:00 am
Urinary track infections are painful, frustrating and all too frequent in women of all ages (and some men, too). Doctors are prescribing the wrong antibiotics to treat them, as well as giving out too ...
- Antibiotics Market Excellent Growth 2021 Top Key Players | Antibiotics market are Allergan, Novartis, Mylan N.Von February 23, 2021 at 9:54 pm
The market research report on the Global Antibiotics Market offered by Straits Research, analyses the major opportunities, CAGR, yearly growth rates to help the readers to understand the qualitative ...
- Three longtime antibiotics could offer alternative to addictive opioid pain relieverson February 22, 2021 at 2:27 pm
Three decades-old antibiotics administered together can block a type of pain triggered by nerve damage in an animal model, UT Southwestern researchers report. The finding, published online today in ...
- Human monoclonal antibodies can act as a substitute for traditional antibioticson February 22, 2021 at 8:59 am
In the course of a new and groundbreaking study, led by Dr, Natalia Freund and the doctoral candidate Avia Waston at the Sackler Medical Faculty, the research group succeeded in isolating monoclonal ...
via Bing News